Cargando…
Copper-64-Labeled 1C1m-Fc, a New Tool for TEM-1 PET Imaging and Prediction of Lutetium-177-Labeled 1C1m-Fc Therapy Efficacy and Safety
SIMPLE SUMMARY: The prevalence of TEM-1 in the vasculature and the stroma of solid tumors and in malignant cells of sarcomas suggests that targeting TEM-1 could have therapeutic benefit. In this context, an anti-TEM-1 companion diagnostic may assist in the personalized medicine approach, whereby TEM...
Autores principales: | Delage, Judith Anna, Gnesin, Silvano, Prior, John O., Barbet, Jacques, Le Saëc, Patricia, Marionneau-Lambot, Séverine, Gouard, Sébastien, Chérel, Michel, Bourgeois, Mickael, Schaefer, Niklaus, Viertl, David, Fierle, Julie Katrin, Dunn, Steven Mark, Faivre-Chauvet, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657097/ https://www.ncbi.nlm.nih.gov/pubmed/34885044 http://dx.doi.org/10.3390/cancers13235936 |
Ejemplares similares
-
Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [(177)Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model
por: Delage, Judith Anna, et al.
Publicado: (2021) -
(177)Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma
por: Delage, J. A., et al.
Publicado: (2020) -
From bench to bedside: (64)Cu/(177)Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applications
por: Gnesin, Silvano, et al.
Publicado: (2023) -
Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)
por: Cicone, Francesco, et al.
Publicado: (2020) -
Single-Dose Anti-CD138 Radioimmunotherapy: Bismuth-213 is More Efficient than Lutetium-177 for Treatment of Multiple Myeloma in a Preclinical Model
por: Fichou, Nolwenn, et al.
Publicado: (2015)